Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • OPEN Health Group Appoints New Leadership

    November 18, 2020 |  

    OPEN Health Group today announced that Rob Barker has been appointed Chief Executive Officer. Rob succeeds outgoing CEO and Co-Founder, David Rowley, who is stepping down after 10 years. A portfolio company of Amulet Capital Partners, LP, OPEN Health is a leading multi-disciplinary health communications and market access group.

    Mr. Barker has approximately 30 years of executive leadership experience in the biopharmaceuticals industry, including multiple roles at leading medical communications and strategy consulting firms. Most recently, he served as CEO of OPEN Health’s Medical Communications practice, having joined the business six years ago.

    Mr. Barker expressed his enthusiasm for the continued growth and success of OPEN Health: “I am excited to be leading such a talented and expert team who have been instrumental in growing OPEN Health to its current position. We are now in a place to take even greater strides forward, and I feel confident that our continued focus on client service and scientific excellence will drive increased growth in the business.”

    “Rob Barker has proven himself as an outstanding strategic and operational leader, and we are confident that he is the ideal executive to lead OPEN Health through its next exciting stage of growth,” said Ramsey Frank, Managing Partner and co-founder of Amulet. Amulet Partner Nick Amigone added, “Medical Affairs, Medical Communications, Market Access and HEOR have taken on increasingly important roles in bringing new therapies to market. Rob has been instrumental in assembling a suite of best-in-class capabilities at OPEN Health and driving the business to achieve its full potential.”

    Mr. Frank added, “David Rowley leaves the business with our enormous thanks. He has grown OPEN Health from an initial idea to a leading global healthcare communications group. All his colleagues at OPEN Health are grateful to him and wish him well for the future. David will work with us in an advisory capacity to ensure a smooth transition.”

    Mr. Rowley said “I have been CEO of OPEN Health since its inception, and I am incredibly proud of the company that we have built. This is the right time for me to be stepping down, and I wish Rob and the whole OPEN Health team continued success.”

    Pink divider

    About OPEN Health

    OPEN Health is a multi-disciplinary health communications and market access group, operating across three core business areas: Medical Communications; Patient and Brand Communications; and Value, Informatics and Evidence. OPEN Health was formed in 2011, and whilst working across a broad therapeutic range has a strong focus on oncology, rare diseases and specialist medicines.

    For more information on OPEN Health, please visit www.openhealthgroup.com.

    About Amulet Capital Partners, LP

    Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in companies. Amulet Capital Partners focuses on those segments it believes have the most attractive long-term fundamentals with a target investment size generally between $25 million to $150 million.

    For additional information, please visit www.amuletcapital.com.

    Pink divider

    Contacts for OPEN Health:

    EU: Carwyn Jones 
    carwynjones@openhealthgroup.com
    +44 20 3386 4728

    USA: Candice Subero
    csubero@openhealthgroup.com
    +1 240-483-4323

    Contact for Amulet Capital Partners:

    Melissa Sheer 
    melissa@kentplacellc.com
    +1 917-690-2199

    This content was provided by OPEN Health

    Company Details

    OPEN Health

    OPEN Health

    Email
    Website

     Latest Content from  OPEN Health 

    Patient journey mapping: exploring the clinical and the emotional journey

    By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...

    OPEN Health announces the integration of Pharmerit International into the group

    OPEN Health has today announced the integration of Pharmerit International, a global leader in health economics and outcomes research (HEOR), into its group of companies.

    OPEN Health mobilised to support outcomes with gene and other advanced therapies

    Harnessing the power of collaborations to bring real insights and improve outcomes

    Spotlight interview: 15 minutes on PR in pharma

    Vicky Bramham, Managing Director, OPEN Health takes 15 minutes to answer some key questions on PR discipline.

    OPEN Health PBC recognised as No. 1 independent creative agency

    We’re No.1! PMLive have named OPEN Health Patient & Brand Communications as the no.1 independent creative healthcare agency. The aim of the PMLive Top 10 lists is to highlight those...

    Spotlight interview: 15 minutes on medical and scientific writing

    Rob Pilbrow, Global Managing Director, Medical Writing, OPEN Health takes 15 minutes to answer some key questions on scientific writing

    Spotlight interview: 15 minutes on healthcare advertising

    Marie Little, Managing Director, OPEN Health Patient & Brand Communications takes 15 minutes to answer some key questions on healthcare advertising

    Alexander Devine Website has gone live!

    As part of the OPEN Health CSR programme one of the charities we support is Alexander Devine. They are a local Children's Hospice based in Maidenhead who provide a truly...

    Spotlight interview: 15 minutes on patient-centricity in pharma

    Sumira Riaz, Health Psychologist at OPEN Health Patient & Brand Communications, takes 15 minutes to answer some key questions on patient-centricity in pharma.

    Spotlight interview: 15 minutes on patient engagement in pharma

    Richard Jones, Managing Director Patient Engagement, OPEN Health Patient and Brand Communications, takes 15 minutes to answer some key questions on patient engagement in pharma